Capital Group Investment Management Pte. Ltd. Bristol Myers Squibb CO Transaction History
Capital Group Investment Management Pte. Ltd.
- $536 Million
- Q2 2025
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 13,287 shares of BMY stock, worth $591,802. This represents 0.11% of its overall portfolio holdings.
Number of Shares
13,287
Previous 13,287
-0.0%
Holding current value
$591,802
Previous $810,000
24.07%
% of portfolio
0.11%
Previous 0.17%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...